CUZZOCREA, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 21.841
EU - Europa 17.808
AS - Asia 4.392
SA - Sud America 40
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 18
AF - Africa 12
Totale 44.138
Nazione #
US - Stati Uniti d'America 21.734
IE - Irlanda 5.637
SE - Svezia 4.399
CN - Cina 3.413
UA - Ucraina 1.981
IT - Italia 1.866
DE - Germania 1.210
FI - Finlandia 825
GB - Regno Unito 713
PL - Polonia 542
SG - Singapore 472
IN - India 286
BE - Belgio 133
RU - Federazione Russa 122
CA - Canada 101
VN - Vietnam 99
FR - Francia 96
AT - Austria 78
CZ - Repubblica Ceca 54
NL - Olanda 40
IR - Iran 26
CL - Cile 22
HK - Hong Kong 19
AU - Australia 18
EU - Europa 16
BR - Brasile 15
BG - Bulgaria 14
CH - Svizzera 14
JP - Giappone 14
RO - Romania 13
IL - Israele 11
HU - Ungheria 10
NZ - Nuova Zelanda 9
ES - Italia 8
RS - Serbia 8
HR - Croazia 7
LV - Lettonia 6
MY - Malesia 6
PT - Portogallo 6
TR - Turchia 6
EE - Estonia 4
KR - Corea 4
LU - Lussemburgo 4
MM - Myanmar 4
SA - Arabia Saudita 4
ZA - Sudafrica 4
BD - Bangladesh 3
DK - Danimarca 3
JO - Giordania 3
KG - Kirghizistan 3
MA - Marocco 3
MX - Messico 3
NO - Norvegia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AR - Argentina 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
EG - Egitto 2
ID - Indonesia 2
IM - Isola di Man 2
MD - Moldavia 2
MT - Malta 2
PA - Panama 2
PH - Filippine 2
PK - Pakistan 2
UG - Uganda 2
CY - Cipro 1
IQ - Iraq 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LT - Lituania 1
MK - Macedonia 1
NP - Nepal 1
PE - Perù 1
PR - Porto Rico 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 44.138
Città #
Dublin 5.635
Chandler 4.060
Jacksonville 4.018
Nyköping 2.856
Beijing 1.389
Princeton 1.133
Ashburn 981
Dearborn 917
Cambridge 821
Des Moines 795
Medford 791
Boardman 705
Messina 672
Ann Arbor 556
Warsaw 528
Lancaster 293
Singapore 277
Jinan 267
Wilmington 261
Shenyang 248
New York 224
Woodbridge 197
San Mateo 169
Pune 166
Nanjing 157
Brussels 132
Hebei 132
Zhengzhou 127
Tianjin 125
Houston 115
Ningbo 109
Haikou 101
Dong Ket 97
Hangzhou 90
Taizhou 85
Guangzhou 82
Seattle 77
Vienna 77
Hyderabad 73
Nanchang 73
Falls Church 69
Washington 67
Catania 64
Ottawa 63
Los Angeles 54
Fuzhou 53
Milan 53
Norwalk 53
Cologne 52
Saint Petersburg 48
Brno 46
Jiaxing 46
Rome 45
Tappahannock 43
Francofonte 42
Changsha 40
Lanzhou 38
Pace 34
Helsinki 33
Cusano Milanino 32
Palermo 30
Taiyuan 28
Edinburgh 24
Naples 20
Lappeenranta 19
Ardabil 18
Auburn Hills 17
Augusta 17
London 17
Misterbianco 17
Chicago 16
Fairfield 16
Bremen 15
Floridia 15
Hefei 15
Turin 15
Florence 14
Hong Kong 14
Sannicandro Di Bari 14
Acireale 13
Catanzaro 13
Kunming 13
Leawood 13
Miechow 13
Munich 13
Marsala 12
Mumbai 12
Napoli 12
Borghetto Santo Spirito 11
Lago 11
Shenzhen 11
Toronto 11
Bologna 10
Monmouth Junction 10
St Louis 10
Amsterdam 9
Brescia 9
College Station 9
Santa Clara 9
Clearwater 8
Totale 31.159
Nome #
Nicolau syndrome following thiocolchicoside injection 204
N-Palmitoylethanolamine-oxazoline (PEA-OXA): A new therapeutic strategy to reduce neuroinflammation, oxidative stress associated to vascular dementia in an experimental model of repeated bilateral common carotid arteries occlusion 116
The association of adelmidrol with sodium hyaluronate displays beneficial properties against bladder changes following spinal cord injury in mice 116
Celenterati Cnidari come modello per lo studio di tossicità da metalli pesanti. 112
Ruolo della melatonina nella prevenzione dello stress ossidativo nell'asfissia neonatale 104
A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models 98
Ethyl-piruvate reduces the developments of zymosine-induced generalized inflammatory in mice 95
Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury 93
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of inflammatory bowel disease 93
The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2 93
Erratum to: Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice. 91
The neuroprotective effects of co-ultraPEALut in a mouse model of spinal cord injury 90
Role of melatonin supplementation in neurodegenerative disorders. 89
Inflammatory and Cell Death Pathways in Brain and Peripheral Blood in Parkinson’s disease. 89
Erratum to: Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain 87
The anti-inflammatory effects of palmitoylethanolamide (PEA) on endotoxin-induced uveitis in rats 86
Dimethyl fumarate reduces inflammatory responses in experimental colitis 85
B-Cell Depletion with CD20 Antibodies as New Approach in the Treatment of Inflammatory and Immunological Events Associated with Spinal Cord Injury 84
Synthesis of bismuth nanoparticles for biomedical applications 84
Melatonin regulates matrix metalloproteinases after traumatic experimental spinal cord injury. 82
The tyrosine kinase inhibitor tyrphostin AG 126 reduces the multiple organ failure induced by zymosan in the rat 78
Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism 78
Role of natural antioxidants and potential use of bergamot in treating rheumatoid arthritis 77
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of acute and chronic inflammation 77
The anti-inflammatory and antioxidant potential of pistachios (Pistacia vera L.) in vitro and in vivo 77
Calpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat 76
Anti-inflammatory and Antioxidant Effects of Flavonoid-Rich Fraction of Bergamot Juice (BJe) in a Mouse Model of Intestinal Ischemia/Reperfusion Injury 76
Dimethyl fumarate attenuates neuroinflammation and neurobehavioral deficits induced by experimental traumatic brain injury 76
Multiple mechanisms of dimethyl fumarate in amyloid β-induced neurotoxicity in human neuronal cells 76
Correction to: Potential eye drop based on a calix[4]arene nanoassembly for curcumin delivery: Enhanced drug solubility, stability, and anti-inflammatory effect (Molecular Pharmaceutics (2017) 14:5 (1610-1622) DOI: 10.1021/acs.molpharmaceut.6b01066) 76
Fumaric Acid Esters Attenuate Secondary Degeneration and Promote Functional Recovery Following Experimental Spinal Cord Injury 75
Absence of endogenous interleukin-6 enhances the inflammatory response during acute pancreatitis induced by cerulein in mice 74
Modeling and biological evaluation of 3.3 '-(1,2- ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor 74
17 beta-estradiol antiinflammatory activity in carrageenan- induced pleurisy 73
The Neuroprotective Effects of Micronized PEA (PEA-m) Formulation on Diabetic Neuropathy in Mice 73
Olprinone attenuates the development of ischemia/reperfusion injury of the gut 72
5-AMINOISOQUINOLINONE REDUCES COLON INJURY BY EXPERIMENTAL COLITIS 71
Matrix metalloproteinase-9 and metalloproteinase-2 activity and expression is reduced by melatonin during experimental colitis. 71
Almond skin reduces oxidative stress and inflammation in an experimental model of inflammatory bowel disease. 71
Liver X receptors activation, through TO901317 binding, reduces neuroinflammation in Parkinson's disease 71
Adelmidrol + sodium hyaluronate in IC/BPS or conditions associated to chronic urothelial inflammation. A translational study 71
2-Pentadecyl-2-Oxazoline reduces neuroinflammatory environment in the MPTP model of Parkinson Disease 71
WY 14643, a potent exogenous PPAR-alpha ligand reduces intestinal injury associated with splanchnic artery occlusion (SAO) shock. 70
Focus: Linguistic, cognitive, and computational perspectives 70
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents 70
Co-micronized palmitoylethanolamide/polydatin treatment causes endometriotic lesion regression in a rodent model of surgically induced endometriosis 70
Adelmidrol, in combination with hyaluronic acid, displays increased anti-inflammatory and analgesic effects against monosodium iodoacetate-induced osteoarthritis in rats 70
Vascular dementia and aliamides: A new approach for the future 70
Nicolau syndrome following thiocolchicoside injection. 69
Astrocytes: Role and Functions in Brain Pathologies 69
Aliamides update: Palmitoylethanolamide and its formulations on management of peripheral neuropathic pain 69
The Association of Palmitoylethanolamide with Luteolin Decreases Autophagy in Spinal Cord Injury 69
Individual and synergistic antioxidative actions of melatonin: studies with vitamin E, vitamin C, glutathione and desferrioxamine (desferoxamine) in rat liver homogenates 68
Absence of endogeneous interleukin-10 enhances the evolution of murine type-II collagen-induced arthritis 68
Inducible nitric oxide synthase mediates bone loss in ovariectomized mice 68
Glycogen synthase kinase 3 beta inhibition reduces the development of nonseptic shock induced by zymosan in mice 68
Antidepressant effect of hypericum perforatum extract on behaviour and neurogenesis in chronic corticosterone-treated mice. 68
Aripiprazole enhances the antidepressant effect of fluoxetine in mice. 68
KU0063794, a Dual mTORC1 and mTORC2 Inhibitor, Reduces Neural Tissue Damage and Locomotor Impairment After Spinal Cord Injury in Mice 68
Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man 68
2-Pentadecyl-2-oxazoline, the oxazoline of PEA, modulates carrageenan-induced acute inflammation 68
2-cyclopenten-1-one and prostaglandin J(2) reduce restenosis after balloon angioplasty in rats: role of NF-kappa B 67
ROSIGLITAZONE A LIGANDS OF THE PEROXISOME PROLIFERATOR-ACTRIVATED RECEPTOR-γ (PPAR-γ), REDUCE THE EVOLUTION OF MURINE TYPE II COLLAGEN-INDUCED ARTHRITIS 67
90 Y-ibritumomab tiuxetan: A nearly forgotten opportunity 67
Role of PPAR-delta in the development of zymosan-induced multiple organ failure: an experiment mice study 67
Effects of tempol, a menbrane-permeable radical scavanger, on the multiple organ failure induced by zymosan in the rat 66
Bone marrow micro-environment is a crucial player for myelomagenesis and disease progression. 66
N-palmitoylethanolamide Prevents Parkinsonian Phenotypes in Aged Mice 66
Adelmidrol: A New Promising Antioxidant and Anti-Inflammatory Therapeutic Tool in Pulmonary Fibrosis 66
UCP2 Regulates Mitochondrial Fission and Ventromedial Nucleus Control of Glucose Responsiveness 66
BENEFICIAL EFFECT OF SUPEROXIDE DISMUTASE MIMETICS IN THE MULTIPLE ORGAN FAILURE INDUCED BY ZYMOSAN IN THE RAT 65
Co-ultramicronized palmitoylethanolamide/luteolin promotes neuronal regeneration after spinal cord injury 65
A flavonoid-rich extract of orange juice reduced oxidative stress in an experimental model of inflammatory bowel disease 65
Laser-produced Au nanoparticles as X-ray contrast agents for diagnostic imaging 65
Anti-inflammatory and neuroprotective effects of co-ultraPEALut in a mouse model of vascular dementia 65
Protective effects of xyloglucan in association with the polysaccharide gelose in an experimental model of gastroenteritis and urinary tract infections 65
Fumaric acid esters attenuate degeneration and promote functional recovery following Parkinson’s disease 65
Laser-generated bismuth nanoparticles for applications in imaging and radiotherapy 65
The tyrosine kinase inhibitor tyrphostin AG 126 reduces the development of colitis in the rat 64
A role for superoxide in gentamicin-mediated nephropathy in rats 64
Design and synthesis of 5-arylidene-2-imino-4-thiazolidinones Celecoxib analogues as antiinflammatory and anticancer agents 64
New therapeutic strategy for Parkinson's and Alzheimer's disease. 64
Neuroprotective effects of olprinone after cerebral ischemia/reperfusion injury in rats. 64
N-palmitoylethanolamine administration ameliorates the clinical manifestation and progression of experimental autoimmune encephalomyelitis in rodents 64
Anti-inflammatory effect of ATB-352, a H2S -releasing ketoprofen derivative, on lipopolysaccharide-induced periodontitis in rats 64
The anti-inflammatory and antioxidant effects of sodium propionate 64
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution 64
Beneficial effects of tempol, a membrane-permeable radical scavenger, on the multiple organ failure induced by zymosan in the rat 63
Role of induced nitric oxide in the initiation of the inflammatory response after postischemic injury 63
reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor gamma 63
5-aminoisoquinolin-1(2H)-one, a water-soluble poly (ADP-ribose) polymerase (PARP) inhibitor reduces the evolution of experimental periodontitis in rats 63
Tempol, a membrane-permeable radical scavenger, reduces dinitrobenzene sulfonic acid-induced colitis 63
Myrtucommulone from Myrtus communis exhibits potent anti-inflammatory effectiveness in vivo 63
Aging and Parkinson's Disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis 63
3,5-Dicaffeoyl-4-malonylquinic acid reduced oxidative stress and inflammation in a experimental model of inflammatory bowel disease 63
5-lipoxygenase knockout mice exhibit a resistance to splanchnic artery occlusion shock 62
Inducible nitric oxide synthase knockout mice exhibit resistance to the multiple organ failure induced by zymosan 62
Neuroprotective effect of almond skins in experimental spinal cord injury 62
TLR-4/Wnt modulation as new therapeutic strategy in the treatment of glioblastomas 62
Rosiglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2), ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut 62
Totale 7.441
Categoria #
all - tutte 189.788
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 189.788


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.995 1.128 496 9 640 58 851 879 732 140 895 1.080 87
2020/20216.793 741 97 1.628 291 488 640 149 797 593 754 308 307
2021/20226.108 91 671 133 187 313 89 466 272 118 382 1.141 2.245
2022/202316.939 1.455 1.208 665 1.366 1.402 1.632 195 1.055 7.007 115 602 237
2023/20244.308 441 740 319 430 369 777 161 249 40 173 84 525
2024/2025252 252 0 0 0 0 0 0 0 0 0 0 0
Totale 45.881